Article Text

Download PDFPDF
Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Handling editor Josef S Smolen

  • Contributors HB and MEO conceived the idea for the study and interpreted the results. HB and ALN performed the clinical follow-up of the patient and her child. DJW and NB performed the laboratory analysis. HB, DJW, NB and MEO critically reviewed the paper. All authors approved the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; externally peer reviewed.